Doctor profile · Federal record

Dr. Mary Toporcer, M.D.

Dermatology Physician (CMS: Dermatology) · Doylestown, PA

  • NPI 1295738458
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 42 yrs in practice
  • Female
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
252 W Swamp RD, Suite 48
Doylestown, PA 189012422
(215) 230-9988
fax (215) 230-9989

Credentials & registration

NPPES · NUCC
NPI registered
May 2005 — 21 yrs on file
Profile last updated
November 6, 2020
Year of graduation
1984 — 42 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
Pennsylvania #MD034027E

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1295738458. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
10,175
Distinct HCPCS
10
Medicare allowed
$499,588
HCPCS Description Services Patients Avg allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 3,000 13 $2
17003 Destruction of precancer skin growth, 2-14 growths 2,578 575 $7
99213 Established patient office or other outpatient visit, 20-29 minutes 1,232 1,070 $95
17000 Destruction of precancer skin growth, 1 growth 1,092 820 $57
99214 Established patient office or other outpatient visit, 30-39 minutes 815 667 $135
17110 Destruction of skin growth, 1-14 growths 499 450 $119
11102 Biopsy of related skin growth, first growth 264 241 $95
99212 Established patient office or other outpatient visit, 10-19 minutes 112 108 $60
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm 86 62 $169
96573 Application of light by qualified health care professional to destroy precancer skin growth 63 55 $249

In context: peer comparison

Among 5 peers in Doylestown Dermatology Physician, average services per provider: 310. This provider delivers 33× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,747
Transactions
91
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, INC. 14 $277.96
Abbvie INC. 18 $204.59
Pfizer INC. 15 $176.11
E.R. Squibb & Sons, L.L.C. 8 $165.91
Sun Pharmaceutical Industries INC. 7 $147.65
Regeneron Healthcare Solutions, INC. 4 $128.69
Ucb, INC. 3 $95.52
Dermavant Sciences, INC. 4 $80.88
Lilly USA, LLC 4 $75.72
Genzyme Corporation 3 $73.43
Leo Pharma INC. 3 $65.46
Novartis Pharmaceuticals Corporation 3 $59.04
Boehringer Ingelheim Pharmaceuticals, INC. 2 $33.20
Galderma Laboratories, L.P. 2 $32.84
Amgen INC. 1 $27.01

By nature of payment

Food and Beverage
$1,747

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
999
Patients
576
Total drug cost
$25,760
Drug Type Claims Patients Total cost
Mupirocin Generic 117 87 $937
Mometasone Furoate Generic 111 98 $1,930
Finasteride Generic 94 33 $1,535
Ketoconazole Generic 94 51 $2,451
Betamethasone Dipropionate Generic 93 76 $4,218
Clobetasol Propionate Generic 80 49 $3,957
Triamcinolone Acetonide Generic 64 42 $607
Doxycycline Hyclate Generic 52 21 $1,460
Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) Brand 51 34 $1,552
Valacyclovir (Valacyclovir Hcl) Brand 47 25 $1,113

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Mary Toporcer's medical specialty?
Dr. Mary Toporcer practices Dermatology Physician in Doylestown, PA.
Where does Dr. Mary Toporcer practice?
Dr. Mary Toporcer practices at 252 W Swamp RD, Doylestown, PA 189012422. Office phone: 2152309988.
What is Dr. Mary Toporcer's NPI?
Dr. Mary Toporcer's National Provider Identifier (NPI) is 1295738458, issued by NPPES.
Does Dr. Mary Toporcer accept Medicare assignment?
Yes. Dr. Mary Toporcer accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mary Toporcer commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.